🇺🇸 FDA
Patent

US 12076418

Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo

granted A61KA61K48/005A61K9/5161

Quick answer

US patent 12076418 (Dually derivatized chitosan nanoparticles and methods of making and using the same for gene transfer in vivo) held by ENGENE, INC. expires Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
ENGENE, INC.
Grant date
Tue Sep 03 2024 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Aug 29 2044 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
25
CPC classes
A61K, A61K48/005, A61K9/5161